Deep Learning Antibiotic Resistance Gene Annotation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current tools for annotating antibiotic resistance genes (ARGs) are limited by reliance on sequence alignment, incomplete databases, and inability to provide comprehensive, automated, and clinically meaningful information, particularly in handling large datasets and detecting point mutations, with most tools being uni-functional and lacking in gene mobility analysis.

Innovation Solution

A hierarchical, multi-task deep learning system using deep convolutional neural networks (CNN) to annotate ARGs from raw sequences, predicting resistant drug type, resistance mechanism, and gene mobility, with a three-tiered module structure that classifies ARGs into beta-lactam sub-types without sequence alignment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If sequence alignment methods are used for ARG annotation, then existing tools can identify known ARGs in databases, but the false negative rate increases and novel ARGs are missed due to database incompleteness

Engineering Contradiction:
ImproveARG detection accuracyVSAvoidnovel ARG detection capability
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent replaces the mechanical sequence alignment system with a deep learning-based system that processes raw sequences directly. The CNN model learns patterns from training data and predicts ARG properties without relying on alignment to existing database sequences, thereby detecting novel ARGs that sequence alignment would miss while maintaining reliability for known ARGs.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental parameter of how sequences are processed - from alignment-based similarity comparison to direct raw sequence processing by neural networks. This parameter change allows the system to capture patterns that are not detectable through traditional alignment methods, improving both reliability and novel ARG detection.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If existing ARG databases are used for annotation, then known ARGs can be identified, but the databases are neither exhaustive nor regularly updated, limiting detection capability

Engineering Contradiction:
Improveannotation speedVSAvoiddetection completeness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent performs preliminary training of the deep learning model on comprehensive ARG data before deployment. This preliminary action creates a robust model that can handle novel and diverse ARGs without requiring continuous database updates during runtime, thus maintaining both productivity and reliability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The deep learning model is designed to be universal, capable of detecting diverse ARG types through multi-task learning. Instead of relying on database-specific alignment rules, the model learns general patterns applicable to various ARG families, making the system more reliable and complete without sacrificing annotation speed.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of operation

If uni-functional tools are used for ARG annotation, then specific tasks can be performed, but comprehensive information including gene mobility and resistance mechanisms cannot be provided simultaneously

Engineering Contradiction:
Improveuser-friendlinessVSAvoidmulti-aspect annotation capability
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent merges multiple annotation functions into a single integrated deep learning system. The multi-task CNN model simultaneously predicts ARG presence, resistance mechanisms, and gene mobility properties from raw sequences, providing comprehensive information in one operation while maintaining ease of use through a unified interface.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The system is designed as a universal annotation platform that performs multiple functions concurrently. The deep learning model handles diverse annotation tasks through multi-task learning, making the tool versatile while remaining easy to operate as a single integrated system rather than requiring multiple separate tools.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Extent of automation

If sequence alignment cutting-off thresholds are used, then annotation can be performed, but careful selection is required which is difficult for users not familiar with the underlying algorithm

Engineering Contradiction:
Improveannotation automationVSAvoidparameter selection complexity
Core Design Contradiction:
Extent of automationVSEase of operation

Solution Approach 1:

The patent replaces the manual threshold selection process with an automated deep learning system. The CNN model automatically determines optimal decision boundaries during training and inference, eliminating the need for users to manually select alignment thresholds. This substitution maintains high automation while dramatically improving ease of operation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS20230260593A1Deep learning-based antibiotic resistance gene prediction system and method
Publication Date: 2023.08.17 KING ABDULLAH UNIV OF SCI & TECH
  • US20230260593A1 patent drawing
  • US20230260593A1 patent drawing
  • US20230260593A1 patent drawing

AI summary

A method for annotating antibiotic resistance genes includes receiving a raw sequence encoding of a bacterium, determining first, in a level 0 module, whether the raw sequence encoding includes an antibiotic resistance gene (ARG), determining second, in a level 1 module, a resistant drug type, a resistance mechanism, and a gene mobility for the ARG, determining third, in a level 2 module, if the ARG is a beta-lactam, a sub-type of the beta-lactam, and outputting the ARG, the resistant drug type, the resistance mechanism, the gene mobility, and the sub-type of the beta-lactam. The level 0 module, the level 1 module and the level 2 module each includes a deep convolutional neural network (CNN) model.